Navigation Links
Clearing the 'fog'
Date:1/15/2009

Many of the side effects from chemotherapy are well documented: Fatigue, nausea and hair and weight loss. But there is another one that has split the medical community about whether is even exists. It's called chemotherapy-induced cognitive deficits or "chemo fog" and pharmacologist Ellen Walker hopes her research not only proves its real, but finds the cause.

Walker, a PhD and associate professor of pharmacodynamics at the School of Pharmacy, received a $1.5 million dollar National Institutes of Health grant at the beginning of this year to study the possible effects of drugs used during chemotherapy on cognitive impairment. It's a big grant, with perhaps even bigger implications for how researchers and patients deal with chemotherapy-induced cognitive deficits, which chemotherapy patients liken to being in a fog, as if they're brain isn't working right. Misplaced items, inability to multi-task, short-term memory loss are hallmarks of the condition. And while there is clinical evidence to support its existence, research studies on the topic are scant.

"My colleague Bob Raffa and I were stunned at the lack of published literature, considering cancer patients have been getting chemotherapy for nearly 50 years," said Walker. "Most studies have looked at how well chemotherapeutic agents kill the tumor, not if they cause a cognitive deficiency, like memory loss."

Walker and Raffa decided to fill that void. Two years ago, Walker and PharmD student John Foley, set out to see if certain chemotherapeutic agents caused memory and learning deficits in mice. They tested two older drugs commonly used to treat breast cancer, a cancer with recently higher survival rates whose survivors have dominated the limited clinical research on chemotherapy-induced cognitive deficits. They suspected the drugs, methotrexate and 5-fluorouracil, weren't toxic alone, but when given together, could cause deficits. Six months into their research, their hunch
'/>"/>

Contact: Megan Chiplock
chiplock@temple.edu
215-707-1731
Temple University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Drexel School of Public Health Uses NetReachs cmScribe Advanced Content Management System (CMS) Software for First National Diversity Preparedness Clearinghouse
2. Blue Cross Blue Shield of Michigan Says Dont Let Snow Be a Pain: Ease into Clearing Sidewalks, Drives
3. Health IT Vendors, Clearinghouses Transforming Patient Insurance Verification Through CAQH National Initiative
4. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
5. After ER visit, many patients in a fog, U-M study finds
6. New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clearing the 'fog'
Clearing the 'fog'
(Date:9/2/2010)... Dotinga HealthDay Reporter , , THURSDAY, Sept. 2 ... news stories about the young, possibly because it makes ... , , "The more time they spent with negative news ... may get some self-esteem boost out of this," said ... State University,s School of Communication. As for young ...
(Date:9/2/2010)... of as trunks in the tree of life. All multi-cellular ... variety other cellskidney, brain, heart or skin, for example. One ... virtually any cell type in the body, making them a ... of age-old diseases or even regrowing defective body parts. , ... shown for the first time that a gene called Myc ...
(Date:9/2/2010)... emergency medical services (EMS) agencies from across the country ... a tool that might point to potential patient safety ... School of Medicine. , The study , ... Prehospital Emergency Care and now available online, analyzed ... and Canada. Researchers adapted a survey used in other ...
(Date:9/2/2010)... treatments build on the benefits of drug therapy, ... and Dr. Kenneth Holroyd from Ohio University in ... various treatment combinations for severe migraine drug ... that those patients receiving the behavioral management program ... their ability to use behavioral skills to effectively ...
(Date:9/1/2010)... New research from the University of New Hampshire ... teenagers who use marijuana are more likely to move ... is overblown. , Whether teenagers who smoked pot ... more to do with life factors such as employment ... fact, the strongest predictor of whether someone will use ...
Breaking Medicine News(10 mins):Health News:Seniors Get Boost From Bad News About the Young 2Health News:Study finds that cancer-causing gene crucial in stem cell development 2Health News:Study finds that cancer-causing gene crucial in stem cell development 3Health News:Safety cultures in EMS agencies vary widely, Pitt study finds 2Health News:Head start for migraine sufferers 2Health News:Risk of marijuana's 'gateway effect' overblown, new UNH research shows 2
... a rate not seen in more than twenty years, creating a ... for small business is being called a top priority at a ... (NFIB) and America,s Health Insurance Plans (AHIP). , ... ...
... benefits can last for years, researchers say , , MONDAY, March ... play: A new study finds the pastime can help adults ... the first parts of vision to be affected by aging. ... minor changes in shades of grey against a uniform background ...
... 44% Over Prior YearVANCOUVER, March 30 /PRNewswire-FirstCall/ - Response ... recorded total revenues of $5,876,337 and a net loss ... ended December 31, 2008. Additionally, the Company announced that ... million in working capital. For a further discussion of ...
... offer improved aesthetic results will help drive the dental ... Mass., March 30 According to Millennium Research Group,s ... Implants 2009 report, although the current economic crisis ... term, the US dental implant market will recover after ...
... ANN ARBOR, Mich., March 30 A ... effective, cheaper medications may create barriers that lead people ... Thomson Reuters study. As a result, patients ultimately require ... called "step therapy," requires health plan members to try ...
... Well Tolerated Throughout Two-Year Study- Conference Call Scheduled ... March 30, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ... results from BLOOM (Behavioral modification and Lorcaserin for ... pivotal trials evaluating the safety and efficacy of ...
Other Medicine News:Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 3Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 2Health News:Response Biomedical Corporation Reports 2008 Financial Results 3Health News:Response Biomedical Corporation Reports 2008 Financial Results 4Health News:Response Biomedical Corporation Reports 2008 Financial Results 5Health News:Dental Implant Market to Exceed $1 Billion by 2013 Despite Current Economic Slowdown 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 2Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 4Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 5Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 6Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 7Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 8Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 9Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 10Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 11
(Date:9/2/2010)... DALLAS, Texas, September 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; ... first one. for (var r in data.results) { first_result = data.results[r]; break; } for ...
(Date:9/2/2010)... Schein, Inc. (Nasdaq: HSIC ), the ... to office-based practitioners, is helping a record number ... and carrying backpacks filled with school supplies and ... Back-to-School program.  This year, the Back-to-School program is ... and Canadian cities.  Since its creation in 1998, ...
(Date:9/1/2010)... CITY, Fla., Sept. 1 Gulf Coast ... of Radiology-accredited radiation oncology center, introduces the Elekta ... at the center,s Open House on Thursday, September ...  Gulf Coast Cancer Treatment Center (GCCTC) is located ... oncologists Dr. D.B. Hurst and Dr. Jefferson Trupp ...
Breaking Medicine Technology:Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 2Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 3Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 4Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 5Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 6Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 7Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports 813th Annual Henry Schein Back-to-School Program Serves Record Number of Children 213th Annual Henry Schein Back-to-School Program Serves Record Number of Children 3Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community 2ApexTwo and SugarCRM Announce New Implementation Partnership 71891 1ApexTwo and SugarCRM Announce New Implementation Partnership 71891 2 2418 5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C Section 71887 1 2418 5 Million New Jersey Medical Malpractice Birth Injury Verdict Due To Cerebral Palsy Caused By A Delayed C Section 71887 2Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 1Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 2Cost Savings from Mobile Health Monitoring to Reach 241 9 billion to 245 8 Billion Globally by 2014 says Juniper Research 71883 3
... is Prostate Cancer Awareness Month, MIAMI and PALM ... Month, and the CyberKnife Centers of Miami and,Palm Beach ... surgery and long treatment courses of radiation. Prostate cancer ... the US., Morse CyberKnife CEO, James G. Schwade, ...
... N.Y., Sept. 2 The many recent reports,documenting ... in,animal models of human disease may actually be ... siRNA to activate an immune,response, according to a ... 9) of ,Human Gene Therapy, a peer-reviewed journal ...
Other Medicine Technology:Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 2Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 3
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display....
The Finstrip combines high performance and flexibility with reliability, simplicity and ease of use....
... has set a standard for ultra-fast washing ... instrument not only processes all 384 wells ... further boost wash performance. This wash procedure ... times as no transport steps to index ...
... Bio-Rad's Model 1575 immunowash ... control of needle position ... routines and maximize wash ... a large choice of ...
Medicine Products: